Ribosomal protein L7 pseudogene 43 (RPL7P43)

Ribosomal protein L7 pseudogene 43 (RPL7P43) is a non-coding, processed pseudogene in the human genome[5][7]. Pseudogenes are DNA segments that resemble functional genes but have lost their protein-coding potential or other functional features due to mutations or lack of regulatory elements. RPL7P43 is related to the ribosomal protein L7 (RPL7), which is a structural component of the 60S ribosomal subunit involved in protein synthesis in cells[1][4]. However, RPL7P43 does not code for a functional protein and does not have any known biological activity, molecular function, or disease association. Pseudogenes like RPL7P43 are common for ribosomal proteins and carry no therapeutic or diagnostic relevance[5][7][9]. RPL7P43 should not be considered a drug target, receptor, enzyme, or core translational component, and there are no known drugs, biomarkers, or safety/efficacy issues associated with it. Note: RPL7P43 is a pseudogene and not a therapeutic target, functional gene, or receptor. Its entry in drug databases or target lists is most likely erroneous or only nominal (reflecting genomic annotation, not biological activity or druggability)[5][7].

Other names

RPL7_23_1260RPL7P43